From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia
Argicolina
Normolip
Argicolina/Normolip rate
At start of treatment
104.2
97.6
106.8 (96.3118.4)
At end of treatment
86.9*
93.1
93.3 (81.0107.4)
Final / Initial %
83.4 (72.0 96.5)
95.4 (85.9106.0)
87.4 (73.3104.1)